OpportunityTitle: Innovation for HIV Vaccine Discovery (R01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from institutions/organizations proposing innovative, high risk, high impact research to identify novel vaccine concepts and targets that will aid in the design and development of an effective immunogen that may provide long-term protection from either acquisition of or ongoing infection by HIV. The emphasis of this FOA is early discovery research that incorporates new ideas leading to the development of newly engineered conventional or entirely novel approaches for vaccines that may have significant impact on the design of immunogens or immunization strategies for an effective HIV vaccine. The program is open to established and new investigators and does not require research expertise in HIV prevention as a prerequisite for submitting an application.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;